Trial intelligence / Profile preview

HBIG, GM-CSF, and HBV Vaccine in Chronic Hepatitis B

NCT01878565Phase 2Unknown

Sponsor
The Fifth Medical Center of the PLA General Hospital
Start
Jun 2013
Primary completion
Dec 2014
Modality
Antibody Conjugates, Recombinant Proteins and Enzymes, Split/Subunit Vaccines
Countries
1
01

Overview

A Phase 2 trial of hepatitis B immune globulin, sargramostim, Hepatitis B vaccine in Chronic Hepatitis B (CHB), sponsored by The Fifth Medical Center of the PLA General Hospital. Status: unknown.

02

Drugs

hepatitis B immune globulinsargramostimHepatitis B vaccine
03

Conditions

Chronic Hepatitis B (CHB)

Beyond the preview

Go deeper on NCT01878565.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01878565.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call